Home / Industry / Pharmaceuticals & Biotechnology / Antimalarial Drugs Market

Antimalarial Drugs Market

Global Antimalarial Drugs Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Drug Class Coverage, By Route of Administration Coverage, By Distribution Channel Coverage, By Geographic Coverage and Leading Companies)

Published Date: Oct 2023 | Format: | No. of Pages: 185

Industry: Pharmaceuticals & Biotechnology | Author Name: Sayali

Request Sample / Information

  
$4,995.00
Buy now
Report Description Research Methodology

FAQ : Antimalarial Drugs Market

The global market for antimalarial drugs has surpassed the US$1.1 billion mark in 2022 and will possibly reach around US$1.5 billion by the end of 2030. The report projects a promising CAGR of more than 5% for the market during 2023 - 2030.

The primary factors projected to drive the global antimalarial drugs market expansion is due to growing expenditure in the healthcare industry, and rising prevalence of malaria.

Hospital pharmacies remain the leading distribution channel, whereas the aminoquinolines represent the most sought-after drug class.

Pfizer Inc., Novartis AG, Roche Holding AG, Merck & Co, Sanofi SA, GlaxoSmithKline Plc, Sun Pharmaceutical Industries Ltd., AbbVie Inc, Bayer AG, and Cipla Limited are some of the biggest names in this industry.

Currently, Asia Pacific spearheads the global industry, and the trend will most likely prevail through the end of 2030.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services